Topical Lidocaine Gel Versus Tetracaine Eye Drops for Panretinal Photo-coagulation in Proliferative Diabetic Retinopathy
DOI:
https://doi.org/10.35790/msj.v6i1.51380Abstract
Panretinal photocoagulation (PRP) is a treatment for proliferative diabetic retinopathy (PDR). The procedure needs anesthetic agent to overcome the pain. Two widely used anesthetic agents are used in this study which are tetracaine 0.5% eyedrops and lidocaine 2% gel. This study aimed to compare the effectivity and efficacy of both anesthetic agents. A prospective randomized controlled trial was done to 40 eyes divided into two groups, group A was treated with tetracaine 0.5% eyedrop and group B with lidocaine 2% gel. Pain score was obtained subjectively from the patient and recorded during four stages of procedure. The results showed that the mean age was 56.5 years in Group A and 53.20 years in group B. Average procedure duration was 8.7 minutes in group A and 9.35 minutes in group B. Average 5 minutes pain level was 3.05 and 2.10 in group A and B consecutively. Average 10 minutes pain level was 2.65 and 2.45 in group A and B consecutively. Average during procedure pain level was 2.70 and 3.40 in group A and Group B, and average post procedure pain level was 1.20 in Group A and 1.55 in Group B. There was no significant difference between both groups’ parameters. In conclusion, the use of both agents is interchangeable and shows no differences in efficacy and effectivity.
Keywords: panretinal photocoagulation; proliferative diabetic retinopathy; anesthetic agent; tetracaine; lidocaine
References
Group DRSR. Photocoagulation treatment of proliferative diabetic retinopathy: clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. Ophthalmology. 1981;88(7):583-600.
Gross JG, Glassman AR, Jampol LM, Inusah S, Aiello LP, Antoszyk AN, et al. Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial. Jama. 2015;314(20):2137-46.
Zakrzewski PA, O'Donnell HL, Lam W-C. Oral versus topical diclofenac for pain prevention during panretinal photocoagulation. Ophthalmology. 2009;116(6):1168-74.
Shiroma HF, Shimono KE, Farah ME, Goldhardt R, Grumann Jr A, Rodrigues EB. Comparative study between lidocaine gel 2% and 5% for ophthalmic procedures. Journal of Ocular Pharmacology and Therapeutics. 2016;32(4):192-5.
Tong JM, Fan MC, Choy BN, Derek K, Li KK. Topical lidocaine gel for panretinal photocoagulation with pattern scanning laser. Ophthalmology Retina. 2018;2(4):379-80.
Alvarez-Verduzco O, Garcia-Aguirre G, de Lourdes Lopez-Ramos M, Vera-Rodriguez S, Guerrero-Naranjo JL, Morales-Canton V. Reduction of fluence to decrease pain during panretinal photocoagulation in diabetic patients. Ophthalmic Surgery, Lasers and Imaging Retina. 2010;41(4):432-6.
Bartfield JM, Holmes TJ, Raccio-Robak N. A comparison of proparacaine and tetracaine eye anesthetics. Academic Emergency Medicine. 1994;1(4):364-7.
Li H, Cheng Y, Li J, Chen Y, Yuan J, Yang S, et al. NaHCO3-buffered lidocaine gel for outpatient rigid cystoscopy in men. Journal of PeriAnesthesia Nursing. 2016;31(2):154-7.
Bartlett JD, Jaanus SD. Clinical Ocular Pharmacology. Elsevier Health Sciences; 2007. p. 85-95.
Jonas JB, Sabanayagam C. Epidemiology and risk factors for diabetic retinopathy. In: Diabetic retinopathy and Cardiovascular Disease. Karger Publishers; 2019. p. 20-37. Doi: 10.1159/000486262
Huang C-X, Lai K-B, Zhou L-J, Tian Z, Zhong X-J, Xu F-B, et al. Long-term effects of pattern scan laser pan-retinal photocoagulation on diabetic retinopathy in Chinese patients: a retrospective study. International Journal of Ophthalmology. 2020;13(2):239.
Hirano T, Iesato Y, Murata T. Multicolor pattern scan laser for diabetic retinopathy with cataract. International Journal of Ophthalmology. 2014;7(4):673.
Mahajan HS, Deshmukh SR. Development and evaluation of gel-forming ocular films based on xyloglucan. Carbohydrate Polymers. 2015;122:243-7.
Tundisi L, Mostaço G, Carricondo PC, Petri D. Hydroxypropyl methylcellulose: physicochemical properties and ocular drug delivery formulations. European Journal of Pharmaceutical Sciences. 2021;159:105736.
Shah H, Reichel E, Busbee B. A novel lidocaine hydrochloride ophthalmic gel for topical ocular anesthesia. Local and regional anesthesia. 2010;3:57-63. Doi: 10.2147/lra.s6453.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Ade J. Nursalim, Vera Sumual, Andrew Chietra, Christian Komaling, Stevanus Loho, Ardelia E. Wulur
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
COPYRIGHT
Authors who publish with this journal agree to the following terms:
Authors hold their copyright and grant this journal the privilege of first publication, with the work simultaneously licensed under a Creative Commons Attribution License that permits others to impart the work with an acknowledgment of the work's origin and initial publication by this journal.
Authors can enter into separate or additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (for example, post it to an institutional repository or publish it in a book), with an acknowledgment of its underlying publication in this journal.
Authors are permitted and encouraged to post their work online (for example, in institutional repositories or on their website) as it can lead to productive exchanges, as well as earlier and greater citation of the published work (See The Effect of Open Access).
